Skip to main content

Advanced Anti-Wrinkle Therapy

NDC 50066-021 · Genomma Lab

Generic nameAvobenxone 3%, Octinoxate 7.5%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 4%
Dosage formCREAM
RouteTOPICAL
Active ingredient(s)AVOBENZONE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE
Strength3; 7.5; 5; 2.7; 4 g/100g; g/100g; g/100g; g/100g; g/100g
Marketing categoryOTC MONOGRAPH NOT FINAL

Packages

50066-021-01 — 1 TUBE in 1 CARTON (50066-021-01) / 42 g in 1 TUBE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

49967-952 — Avobenzone, Octisalate and Octocrylene, 49967-964 — Homosalate, Octisalate and Octocrylene, 49967-969 — Octinoxate, 49967-971 — Avobenzone, Homosalate, Octisalate, Octocrylene and Oxybenzone, 49967-976 — Octinoxate, 49967-990 — Avobenzone, Homosalate, Octisalate and Octocrylene, 49967-992 — Homosalate, Octisalate, Octocrylene and Zinc oxide, 49967-994 — Avobenzone, Homosalate, Octisalate and Octocrylene, 49967-995 — Titanium Dioxide, 49967-996 — Avobenzone, Homosalate, Octisalate and Octocrylene, 50066-119 — Avobenzone, Octocrylene, Oxybenzone, 50066-181 — Avobenzone, Homosalate, Octisalate, Octocrylene, 50090-6558 — Avobenzone, Homosalate, Octisalate, and Octocrylene, 50184-0600 — Avobenzone, Homosalate, Octisalate and Octocrylene, 50184-1013 — Avobenzone, Octinoxate, Octocrylene, 50390-001 — ENSULIZOLE,OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE, ZINC OXIDE, 50390-002 — ENSULIZOLE,OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE, ZINC OXIDE, 50390-004 — ENSULIZOLE, OCTINOXATE, ZINC OXIDE, 50390-010 — ENSULIZOLE, OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE, ZINC OXIDE, 50390-011 — ENSULIZOLE, OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE, ZINC OXIDE, +4562 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels